Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Shigeno
BCL-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated With Taxane-Based Chemotherapy
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Taxane Chemotherapy for Hormone-Naïve Prostate Cancer With Its Expanding Role as Breakthrough Strategy
Frontiers in Oncology
Cancer Research
Oncology
Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy
Oncologist
Cancer Research
Medicine
Oncology
Is BCL-2 a Predictive Marker of Neoadjuvant Chemotherapy Response in Patients With Urothelial Bladder Cancer Undergoing Radical Cystectomy?
Scandinavian Journal of Urology
Urology
Nephrology
Hormone-Refractory Prostate Cancer
BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated With Cisplatin- Or Docetaxel-Based Chemotherapy/Chemoradiotherapy
PLoS ONE
Multidisciplinary
PSA Levels and Prognosis in Patients With Hormone-Refractory Prostate Cancer Treated With Low-Dose Dexamethasone
Japanese Journal of Urology
Urology
Therapeutic Approach to Hormone-Refractory Prostate Cancer
Oncology & Hematology Review (US)
Article on BCL-2 as a Prognostic Marker
Clinical Cancer Research
Cancer Research
Oncology
ERCC1 Expression as a Predictive Marker of Squamous Cell Carcinoma of the Head and Neck Treated With Cisplatin-Based Concurrent Chemoradiation
British Journal of Cancer
Cancer Research
Oncology
